Kingdon Capital Management’s SteadyMed Ltd STDY Stock Holding History

Kingdon Capital Management’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-503,140	Closed	-$2.26M	–	140
2018 Q2	$2.26M	Hold	503,140	–	–	0.16%	94
2018 Q1	$1.64M	Hold	503,140	–	–	0.13%	97
2017 Q4	$1.86M	Hold	503,140	–	–	0.12%	102
2017 Q3	$1.69M	Hold	503,140	–	–	0.11%	99
2017 Q2	$3.17M	Buy	+503,140	New	+$3.42M	0.22%	77

Other funds holding STDY

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return

HCMT

Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Kingdon Capital Management's STDY Position: Q3 2018 in Review

Kingdon Capital Management sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 503,140 shares — an estimated $2.26M sold.

Kingdon Capital Management first reported a position in STDY in Q2 2017 and held it in 5 quarters. The position peaked at $3.17M in Q2 2017. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

Kingdon Capital Management reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
Kingdon Capital Management sold 503,140 SteadyMed Ltd shares in Q3 2018, an estimated $2.26M.
Kingdon Capital Management first reported a position in SteadyMed Ltd in Q2 2017 and held it in 5 quarters.
Kingdon Capital Management's SteadyMed Ltd position peaked at $3.17M in Q2 2017.
5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Kingdon Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.